Aiming to become the global leader in chip-scale photonic solutions by deploying Optical Interposer technology to enable the seamless integration of electronics and photonics for a broad range of vertical market applications

Free
Message: Prospectus Supplement- Dilution consequences

It was my belief that the company was waiting for the Annual filing before issuing any material news.Now it is likely that there will be a full update re' OFC conference, with positive news .

The Prospectus states that they can sell up to US$ 24,123,758  worth of stock, which at latest close of US$1.30 is about 18,556,737 shares, which represents a dilution of about 39%, taking current declared outstanding shares at 47,660,352.

However if the market cap' of the company is below US$75MN then they can only sell 1/3rd of outstanding shares , about 15,886,784 shares, or appx 33% dilution, which at current close of US$1.30 would realize US$20.65 MN.

All the above assumes they sell the full amount of US$24.12 MN.

 One now hopes and expects that Poet will start releasing a series of positive news releases (technical & commercial) to increase  share value and minimize dilution.

Not sure if supplement to Prospectus has yet to be approved before it becomes effective.

Hopefully Poet, or the broker, has some heavy duty investors lined up to take this whole offering.

This is definitely not the non-dilutive financing that was promised but hopefully it is cost efficient, and gives the company some runway to get the rocket launched.

milagro

 

 

 

 

Share
New Message
Please login to post a reply